Nerve Fresh Reviews (URGENT REPORT) Consumer Complaints, Ingredients & What Doctors Reveal About Side Effects in 2025 
Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Requirement
CHICAGO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated...
Aptose’s Tuspetinib Exceeds Expectations When Combined with Standard of Care Treatment Across Diverse Populations of Newly Diagnosed AML
Data from Phase 1/2 TUSCANY trial presented at the European School of Haematology (ESH) 7th International ConferenceAddition of TUS to...
C4 Therapeutics Announces Pricing of $125 Million Underwritten Offering
$125 Million in Upfront Proceeds Expected to Fund Next Phase of Cemsidomide Multiple Myeloma Development Including Registrational Phase 2 Trial...
Dianthus Therapeutics Announces Exclusive License Agreement with Leads Biolabs for DNTH212, a First and Potentially Best-In-Class, Phase 1 Ready Bifunctional BDCA2 & BAFF/APRIL Inhibitor for Severe Autoimmune Diseases
DNTH212 is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously...
Agios to Host Third Quarter 2025 Financial Results Conference Call and Webcast on October 30 at 8:00 a.m. ET
CAMBRIDGE, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative...
Conavi Medical to Present at the Planet MicroCap Showcase: TORONTO in partnership with MicroCapClub on Wednesday, October 22, 2025
TORONTO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage...
Verano Elevates Expanding Vape Product Portfolio with Exclusive, First-to-Market Launch of Revolutionary HYPHEN System
HYPHEN features brand new best-in-class technology that allows consumers to flex between extracts, size formats and brands through interchangeable vape...
Gain Therapeutics to Attend the 2025 Maxim Growth Summit
BETHESDA, Md., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology...
Apellis Pharmaceuticals to Host Conference Call on October 30, 2025, to Discuss Third Quarter 2025 Financial Results
Apellis Pharmaceuticals to Host Conference Call on October 30, 2025, to Discuss Third Quarter 2025 F, Oct. 16, 2025 (GLOBE...
National PKU Alliance Grant Advances Engineered Native Bacteria Candidate for Phenylketonuria (PKU)
San Diego, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Endure Biotherapeutics, Inc. (Endure Bio®), a pioneer in engineered engraftable microbial therapeutics,...
Cellectis Hosts R&D Day Today Showcasing Pipeline Progress and Long-Term Value Drivers
Event features full Phase 1 data and pivotal Phase 2 strategy for lasme-cel (UCART22) in r/r B-ALL NEW YORK, Oct....
Foghorn Therapeutics Announces Significant Progress for Selective ARID1B Degrader at the 8th Annual TPD and Induced Proximity Summit
Foghorn to host a virtual investor event on updates for its Selective ARID1B, Selective CBP and Selective EP300 degrader programs...
Cheelcare Appoints Dave Jones as Director of U.S. Sales
Toronto, Ontario--(Newsfile Corp. - October 16, 2025) - Cheelcare Inc. (TSXV: CHER) ("Cheelcare" or the "Company"), a Canadian leader in...
MOEA DoIT Showcases 65 Cutting-Edge Technologies at TIE
Unveiling AI Clothing Sorting System and New Equipment for Depression Treatment TAIPEI, Oct. 16, 2025 /PRNewswire/ -- The Department of...
C-Path’s Disease Modeling Coalition Begins Global Pediatric IBD Work from European Hub
AMSTERDAM, Oct. 16, 2025 /PRNewswire/ -- Critical Path Institute® (C-Path) today announced the official launch of the Critical Path Disease...
HoneyNaps Concludes a Meaningful Participation at World Sleep 2025 — Global Spotlight on AI Sleep Medicine Technology
Six contracts signed — business expansion accelerates across Europe, Latin America, and the Middle East FDA-approved AI PSG Auto-scoring solution SOMNUM...
Ohio County Board of Development Disabilities Teams Up with VR Developer to Create Online Safety Training for Neurodivergent Youth and Adults
New series of simulations developed by Floreo in partnership with Cuyahoga County Board of Development Disabilities addresses gaps in online...
Plush.MD Advances Regenerative Aesthetics as the Future of Cosmetic Medicine
As regenerative treatments gain traction in the aesthetics industry, Susan Stevens Tanne, M.D. of Plush.MD brings science-based rejuvenation to the...
ANGLE plc Announces Appointments: Interim CEO and Senior Board Advisor
GUILFORD, SURREY / ACCESS Newswire / October 16, 2025 / ANGLE plc (to be renamed CelLBxHealth plc) (AIM:AGL)(OTCQX:ANPCY), a world-leading...
VTT identifies new plant-based anti-inflammatory and anti-ageing ingredients for sustainable cosmetics
ESPOO, Finland, Oct. 15, 2025 /PRNewswire/ -- In a landmark collaborative project, scientists at the VTT Technical Research Centre of...